Bimokalner

N/A

Report date: 2025/05/28 11:25:51
NME

Base Information

Drug NameBimokalner
Drug Alias NameACOU-085
ClassificationSmall molecules
Mechanisms of ActionPotassium voltage-gated channel subfamily KQT member 4 agonists
TargetsPotassium voltage-gated channel subfamily KQT member 4
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAcousia Therapeutics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesAcousia Therapeutics GmbH
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A